Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,172
Closed -$822K 397
2026
Q1
$822K Buy
2,172
+381
+21% +$163K 0.06% 258
2025
Q4
$795K Buy
+1,791
New +$780K 0.1% 238
2024
Q3
Sell
-1,576
Closed -$855K 458
2024
Q2
$855K Buy
+1,576
New +$903K 0.1% 233
2024
Q1
Sell
-1,214
Closed -$710K 427
2023
Q4
$710K Buy
1,214
+536
+79% +$300K 0.06% 290
2023
Q3
$352K Buy
678
+241
+55% +$125K 0.03% 378
2023
Q2
$237K Buy
+437
New +$239K 0.03% 302
2023
Q1
Sell
-784
Closed -$400K 543
2022
Q4
$400K Buy
+784
New +$382K 0.06% 310

Other funds holding CHE

FORA Capital's CHE Position: Q2 2026 in Review

FORA Capital sold out of Chemed (CHE) in Q2 2026, closing a stake of 2,172 shares — an estimated $822K sold.

FORA Capital first reported a position in CHE in Q4 2022 and held it in 7 quarters. The position peaked at $855K in Q2 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • FORA Capital reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • FORA Capital sold 2,172 Chemed shares in Q2 2026, an estimated $822K.
  • FORA Capital first reported a position in Chemed in Q4 2022 and held it in 7 quarters.
  • FORA Capital's Chemed position peaked at $855K in Q2 2024.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.